SM
SRRA

Sabby Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Sabby Management’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-13,339
Closed -$827K – 204
2017
Q3 		$827K Sell
13,339
-28,223
-68% -$1.66M 0.05% 85
2017
Q2 		$1.95M Sell
41,562
-2,095
-5% -$107K 0.13% 70
2017
Q1 		$2.67M Buy
43,657
+20,136
+86% +$1.17M 0.14% 73
2016
Q4 		$1.4M Buy
23,521
+6,328
+37% +$395K 0.08% 129
2016
Q3 		$1.25M Buy
17,193
+2,443
+17% +$189K 0.05% 164
2016
Q2 		$1.17M Buy
+14,750
New +$2.81M 0.06% 151

Other funds holding SRRA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sabby Management's SRRA Position: Q4 2017 in Review

Sabby Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q4 2017, closing a stake of 13,339 shares — an estimated $827K sold.

Sabby Management first reported a position in SRRA in Q2 2016 and held it in 6 quarters. The position peaked at $2.67M in Q1 2017. 51 funds tracked by Wall St. Rank hold SRRA as of Q4 2017.

  • Sabby Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Sabby Management sold 13,339 Sierra Oncology, Inc. Common Stock shares in Q4 2017, an estimated $827K.
  • Sabby Management first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2016 and held it in 6 quarters.
  • Sabby Management's Sierra Oncology, Inc. Common Stock position peaked at $2.67M in Q1 2017.
  • 51 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q4 2017.

Based on Sabby Management's 13F filing for Q4 2017, filed 14 Feb 2018.